Enzo Biochem, Inc. announced that it has been notified by the New York Stock Exchange (NYSE) of its non-compliance with listing standards due to its market capitalization and stockholder equity ...
Enzo Biochem reported a 20% revenue decline in Q3 2025, with ongoing strategic reviews and a class-wide settlement following a cyber incident. Enzo Biochem, Inc. reported financial results for its ...
Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction Provided by GlobeNewswire Apr 22, 2025 5:30am ...
There wouldn't be many who think Enzo Biochem, Inc.'s (NYSE:ENZ) price-to-sales (or "P/S") ratio of 1.3x is worth a mention when the median P/S for the Healthcare industry in the United States is ...
FARMINGDALE, NY, April 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo Biochem” or the “Company”), a leading biosciences and diagnostics company, today announced that ...
Enzo Biochem Inc. shares surged Monday after the company said a federal court judge upheld a ruling in Enzo's favor in a patent infringement lawsuit. THE SPARK: The jury in the case awarded Enzo ...
Enzo Biochem, Inc. (NYSE:ENZ) announced today that it has arranged an $8 million senior secured revolving line of credit that may be increased to $12 million with Healthcare Finance Group, LLC ...
Our AI model demonstrates 23% historical accuracy for ENZ predictions, based on advanced machine learning algorithms trained on over 10 years of market data.